The TGA is seeking feedback on proposed changes to the Therapeutic Goods Advertising Code (No. 2) 2018 (the Code). The consultation closes on 18 June 2021.

The consultation provides that the changes/improvements proposed by the TGA are intended to minimise unnecessary compliance costs while continuing to ensure that advertising does not contribute to any unsafe or improper use of advertised products.

Different mechanisms for improving the Code have been proposed; for some provisions, minor wording changes have been proposed as well as the addition of new definitions and notes to improve clarity; for others, feedback is sought on options for combining provisions and other more significant changes.

CMA will be examining the proposed changes in detail and we encourage members to read today’s technical alert for more information on the consultation, including a summary of proposed changes and how to respond.